- Home
- RGC vs ME Comparison
RGC vs ME Comparison
Compare RGC & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- ME
- Stock Information
- Founded
- RGC 2014
- ME 2006
- Country
- RGC Hong Kong
- ME United States
- Employees
- RGC N/A
- ME N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- ME Precision Instruments
- Sector
- RGC Health Care
- ME Health Care
- Exchange
- RGC Nasdaq
- ME Nasdaq
- Market Cap
- RGC 105.3M
- ME 113.9M
- IPO Year
- RGC 2021
- ME N/A
- Fundamental
- Price
- RGC $4.87
- ME $3.24
- Analyst Decision
- RGC
- ME Hold
- Analyst Count
- RGC 0
- ME 1
- Target Price
- RGC N/A
- ME $9.40
- AVG Volume (30 Days)
- RGC 51.3K
- ME 393.2K
- Earning Date
- RGC 12-20-2024
- ME 02-05-2025
- Dividend Yield
- RGC N/A
- ME N/A
- EPS Growth
- RGC N/A
- ME N/A
- EPS
- RGC N/A
- ME N/A
- Revenue
- RGC N/A
- ME $193,260,000.00
- Revenue This Year
- RGC N/A
- ME $21.93
- Revenue Next Year
- RGC N/A
- ME $17.31
- P/E Ratio
- RGC N/A
- ME N/A
- Revenue Growth
- RGC N/A
- ME N/A
- 52 Week Low
- RGC $3.03
- ME $2.66
- 52 Week High
- RGC $32.44
- ME $19.38
- Technical
- Relative Strength Index (RSI)
- RGC 36.17
- ME 38.88
- Support Level
- RGC $5.41
- ME $3.26
- Resistance Level
- RGC $6.10
- ME $3.50
- Average True Range (ATR)
- RGC 0.42
- ME 0.35
- MACD
- RGC -0.10
- ME 0.04
- Stochastic Oscillator
- RGC 1.14
- ME 12.26
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.